NCDs, Part III: Agency Mandates, Decisions, Coverage, and Access

Avalere Essential Voice

English - September 14, 2022 19:01 - 9 minutes - 13.6 MB
Medicine Health & Fitness Science Life Sciences Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: NCDs, Part II: Evidence Development to Fulfill CED Requirements

Next Episode: RSV Prevention, Part I: Pediatric Monoclonal Antibodies

Tune into the third episode in the Avalere Health Essential Voice podcast series focused on Agency decisions define patient access. In this segment, our experts continue the conversation around national coverage determinations (NCDs) by considering how potential policy and market catalysts 3 to 5 years out may help stakeholders think through opportunities and risks at key decision points ranging from early in development to implications for Part D.